Literature DB >> 15334620

Treatment of vitiligo by 308-nm excimer laser: an evaluation of variables affecting treatment response.

N Ostovari1, T Passeron, W Zakaria, E Fontas, J C Larouy, J F Blot, J Ph Lacour, J P Ortonne.   

Abstract

BACKGROUND AND OBJECTIVES: To determine the true efficacy of the 308-nm excimer laser for the treatment of vitiligo, while taking into account confounding factors such as anatomic site of treatment, age, sex, skin type, MED, and duration of evolution of the vitiligo. STUDY DESIGN/
MATERIALS AND METHODS: Thirty-five patients with vitiligo were included. Each lesion was treated twice a week by the 308-nm excimer laser for a maximum of 24 sessions. Efficacy was blindly evaluated by two independent physicians.
RESULTS: Repigmentation was noted in 46 plaques/52 (88.5%). Repigmentation rate (75%) was obtained in 14 (26.9%). In "UV sensitive" areas (face, neck, trunk), 8/14 lesions (57.1%) had a repigmentation rate, 75% versus 6/38 (15.8%) in "UV resistant" areas (bony prominences and extremities) (P = 0.031). No relationship could be established between response to the treatment and the following variables: age, sex, skin type, MED, and duration of evolution of the vitiligo (respectively, P = 1, 0.666, 0.566, 0.628, 0.521).
CONCLUSIONS: An aesthetically reasonable result is achieved essentially in "UV sensitive" areas, thus appearing to be the appropriate places of choice for this treatment.

Entities:  

Mesh:

Year:  2004        PMID: 15334620     DOI: 10.1002/lsm.20057

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  10 in total

1.  Targeted Broadband UVB Phototherapy forthe Treatment of Localized Vitiligo.

Authors:  Jeong Eun Kim; Hyo Hyun Ahn; Young Chul Kye
Journal:  Ann Dermatol       Date:  2008-09-30       Impact factor: 1.444

Review 2.  Highlights in pathogenesis of vitiligo.

Authors:  Ghada F Mohammed; Amal Ha Gomaa; Mohammed Saleh Al-Dhubaibi
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

Review 3.  [The 308 nm Excimer laser : Treatment of vitiligo and hypopigmentation].

Authors:  K Fritz; C Salavastru
Journal:  Hautarzt       Date:  2018-01       Impact factor: 0.751

Review 4.  Effectiveness of a 308-nm excimer laser in treatment of vitiligo: a review.

Authors:  Alauldin Khalef Alhowaish; Nathalie Dietrich; Meltem Onder; Klaus Fritz
Journal:  Lasers Med Sci       Date:  2012-08-15       Impact factor: 3.161

5.  Maintenance therapy of adult vitiligo with 0.1% tacrolimus ointment: a randomized, double blind, placebo-controlled study.

Authors:  Marine Cavalié; Khaled Ezzedine; Eric Fontas; Henri Montaudié; Emeline Castela; Philippe Bahadoran; Alain Taïeb; Jean-Philippe Lacour; Thierry Passeron
Journal:  J Invest Dermatol       Date:  2014-12-18       Impact factor: 8.551

Review 6.  308nm excimer laser in dermatology.

Authors:  Shadi Mehraban; Amir Feily
Journal:  J Lasers Med Sci       Date:  2014

7.  Original article title: "Comparison of therapeutic efficacy of topical corticosteroid and oral zinc sulfate-topical corticosteroid combination in the treatment of vitiligo patients: a clinical trial".

Authors:  Reza Yaghoobi; Mohammad Omidian; Nooshin Bagherani
Journal:  BMC Dermatol       Date:  2011-03-31

8.  Electrocautery Needling and the 308-nm Excimer Lamp: A Synergistic Combination for the Treatment of Stable Non-segmental Vitiligo.

Authors:  Lili Yang; Pui Mun Wong; Lingli Yang; Ichiro Katayama; Huali Wu; Huimin Zhang
Journal:  Dermatol Ther (Heidelb)       Date:  2020-05-21

Review 9.  The use of lasers in vitiligo, an overview.

Authors:  N F Post; N Ezekwe; V S Narayan; M W Bekkenk; N Van Geel; I Hamzavi; T Passeron; A Wolkerstorfer
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-03-01       Impact factor: 9.228

Review 10.  Vitiligo in Children: What's New in Treatment?

Authors:  Serena Gianfaldoni; Georgi Tchernev; Uwe Wollina; Jacopo Lotti; Miriam Rovesti; Francesca Satolli; Katlein França; Torello Lotti
Journal:  Open Access Maced J Med Sci       Date:  2018-01-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.